Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals Inc (NY: AMRX )

4.360 USD UNCHANGED
Streaming Delayed Price Updated: 6:59 PM EDT, Oct 29, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.360
Bid (Size) 3.490 (1)
Ask (Size) 6.730 (10)
Prev. Close 4.360
Today's Range 4.360 - 4.360
52wk Range 2.400 - 5.790
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amneal to Report Third Quarter 2020 Results on November 6, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2020 financial results on Friday, November 6, 2020, prior to market open. The Company will host... 
From Business Wire News Releases
Spectrum Brands Holdings Appoints Gautam Patel and Anne S. Ward to the Board of Directors
Spectrum Brands Holdings Appoints Gautam Patel and Anne S. Ward to the Board of Directors 
From Business Wire News Releases

Performance

YTD
-8.60%
-8.60%
1 Month
+13.25%
+13.25%
3 Month
N/A
N/A
6 Month
+20.11%
+20.11%
1 Year
+36.68%
+36.68%

More News

Read More
Wishbone Medical Appoints Jeff George to Board of Directors
From GlobeNewswire News Releases
Company Profile for Amneal Pharmaceuticals
Tags Amneal Pharmaceuticals, Inc.
From Business Wire News Releases
Amneal & PL Developments Launch Store Brand Program of Over-the-Counter (“OTC”) Diclofenac Sodium Topical Gel, 1%
From Business Wire News Releases
Amneal to Virtually Participate at the Morgan Stanley Global Healthcare Conference
From Business Wire News Releases
Amneal Receives Abbreviated New Drug Application Approval for Lidocaine Patch, 5%
From Business Wire News Releases
Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer
From GlobeNewswire News Releases
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
From GlobeNewswire News Releases
Amneal Reports Second Quarter 2020 Financial Results
From Business Wire News Releases
Amneal Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for AMRX
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.